MedPath

The Aaron Diamond Aids Research Center For City Of New York, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:1

Trial Phases

1 Phases

Phase 1:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Phase 1
2 (100.0%)

A Study of Tucaresol in HIV-Infected Patients Who Are Taking Other Anti-HIV Drugs

Phase 1
Conditions
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2005-06-24
Lead Sponsor
Aaron Diamond AIDS Research Center
Target Recruit Count
24
Registration Number
NCT00006209
Locations
🇺🇸

Rockefeller Univ, New York, New York, United States

Placebo-Controlled Trial of Safety and Efficacy of Thalidomide in Patients With Infections Due to Mycobacterium and/or HIV

Phase 1
Completed
Conditions
Mycobacterium Avium-Intracellulare Infection
HIV Infections
Tuberculosis, Mycobacterium Infection
First Posted Date
2001-08-31
Last Posted Date
2005-06-24
Lead Sponsor
Aaron Diamond AIDS Research Center
Registration Number
NCT00002104
Locations
🇺🇸

Bellevue Hosp Ctr, New York, New York, United States

🇺🇸

Aaron Diamond AIDS Rsch Ctr / Rockefeller Univ, New York, New York, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.